GSK to shut down UK an­tibi­ot­ic fa­cil­i­ty fol­low­ing end of San­doz con­tract

GSK is clos­ing down a fa­cil­i­ty and is wind­ing down an­tibi­ot­ic man­u­fac­tur­ing op­er­a­tions at an­oth­er fac­to­ry as No­var­tis’ San­doz choos­es to end its four-year con­tract …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER